Ethyl Acetate → HCID 67812581, compound

HRID 2401369Notes

Reaction equation

HRID 2401369 reaction equation
[Cl-].[C:2]([O:6][C:7](=[O:10])[CH2:8][Zn+])([CH3:5])([CH3:4])[CH3:3].[Cl:11][C:12]1[CH:40]=[CH:39][C:15]([C:16]([C:18]2[C:22]([CH3:23])=[C:21]([CH3:24])[S:20][C:19]=2[C:25]2[C:26]([CH3:38])=[N:27][O:28][C:29]=2/[CH:30]=[N:31]/[S@@:32]([C:34]([CH3:37])([CH3:36])[CH3:35])=[O:33])=[O:17])=[CH:14][CH:13]=1.[NH4+].[Cl-].CCOC(C)=O>C1COCC1>[Cl:11][C:12]1[CH:13]=[CH:14][C:15]([C:16]([C:18]2[C:22]([CH3:23])=[C:21]([CH3:24])[S:20][C:19]=2[C:25]2[C:26]([CH3:38])=[N:27][O:28][C:29]=2[C@H:30]([NH:31][S@@:32]([C:34]([CH3:35])([CH3:36])[CH3:37])=[O:33])[CH2:8][C:7]([O:6][C:2]([CH3:5])([CH3:4])[CH3:3])=[O:10])=[O:17])=[CH:39][CH:40]=1.[Cl:11][C:12]1[CH:13]=[CH:14][C:15]([C:16]([C:18]2[C:22]([CH3:23])=[C:21]([CH3:24])[S:20][C:19]=2[C:25]2[C:26]([CH3:38])=[N:27][O:28][C:29]=2[C@@H:30]([NH:31][S@@:32]([C:34]([CH3:35])([CH3:36])[CH3:37])=[O:33])[CH2:8][C:7]([O:6][C:2]([CH3:5])([CH3:4])[CH3:3])=[O:10])=[O:17])=[CH:39][CH:40]=1

Participants

7

Procedure

To a cooled (0° C.) solution of (2-tert-butoxy-2-oxoethyl)zinc(II) chloride (0.200 mL, 0.100 mmol) was added a solution of (R,E)-N-((4-(3-(4-chlorobenzoyl)-4,5-dimethylthiophen-2-yl)-3-methylisoxazol-5-yl)methylene)-2-methylpropane-2-sulfinamide (0.039 g, 0.084 mmol) in THF (0.5 mL). Additional THF (2×0.5 mL) was used to aid in complete transfer of the sulfinamide. After 1.5 h, additional (2-tert-butoxy-2-oxoethyl)zinc(II) chloride (1.00 mL, 0.500 mmol) was added and the reaction temperature was allowed to reach to ambient temperatures. After several hours, the reaction mixture was diluted aqueous saturated NH4Cl and EtOAc. The aqueous layer was extracted with EtOAc (2×), the combined organic phase was washed with water (2×), dried over Na2SO4 and concentrated in vacuo to give a thick oil. The resultant oil was purified on Biotage system (gradient elution, 12% MTBE:95% Hexanes to 100% MTBE) to deliver the (3R)-tert-butyl 3-(4-(3-(4-chlorobenzoyl)-4,5-dimethylthiophen-2-yl)-3-methylisoxazol-5-yl)-3-((R)-1,1-dimethylethylsulfinamido)propanoate (0.016 g, 0.027 mmol, 31% yield) as a light white foam and (3S)-tert-butyl 3-(4-(3-(4-chlorobenzoyl)-4,5-dimethylthiophen-2-yl)-3-methylisoxazol-5-yl)-3-((R)-1,1-dimethylethylsulfinamido)propanoate (0.021 g, 0.036 mmol, 43% yield) as a light white foam. (3R)-tert-butyl 3-(4-(3-(4-chlorobenzoyl)-4,5-dimethylthiophen-2-yl)-3-methylisoxazol-5-yl)-3-((R)-1,1-dimethylethylsulfinamido)propanoate: LC/MS m/z 579 [(M (35Cl)+H]+ and m/z 581 [(M (37Cl)+H]+ and (3S)-tert-butyl 3-(4-(3-(4-chlorobenzoyl)-4,5-dimethylthiophen-2-yl)-3-methylisoxazol-5-yl)-3-((R)-1,1-dimethylethylsulfinamido)propanoate: LC/MS m/z 579 [M+H]+.

Workup

  1. waitAfter several hours
  2. extractionThe aqueous layer was extracted with EtOAc (2×)
  3. washthe combined organic phase was washed with water (2×)
  4. dry with materialdried over Na2SO4
  5. concentrationconcentrated in vacuo
  6. customto give a thick oil
  7. customThe resultant oil was purified on Biotage system (gradient elution, 12% MTBE:95% Hexanes to 100% MTBE)

Sources & evidence

ORD record
ord-bbd7d917029e4278a2441dfab5b5690d
Source dataset
uspto-grants-2014_08
Patent number
US08796261B2

Reaction notes

Loading…